An analysis comparable to our work assessed chromogranin A (CgA) regarding recurrence after panNEN surgery [8], combining CgA (>5× upper normal limit) with tumor size (≥4 cm) and G2/G3 grading to design a preoperative risk score. The gene discussed is CGA; the disease is neoplasm.